Susan Silbermann is president and general manager of Pfizer Vaccines, responsible for commercial development of the portfolio of preventative vaccines to address unmet medical needs and treat serious or life-threatening conditions. She leads a team that partners with government and global civic organizations to maximize Pfizer’s impact on public health. Throughout her career at Pfizer, Silbermann has held numerous leadership positions in marketing, commercial development, and general management in domestic and international markets. She sits on the Vaccines CEO Steering Committee at the International Federation of Pharmaceutical Manufacturers and Associations, the board of advisors for Catalyst, and the corporate advisory board for the Johns Hopkins University Carey Business School. (Festival Underwriter Presenter)
Previously
Pharmaceutical advances are expanding, with some exciting new drugs already on the market and others ready to emerge from the pipeline. These therapeutics offer fresh hope fo...